4
Changes in Ownership
SpyGlass Pharma, Inc. Filed Acc 0001753143-26-000006
Director bought 312,500 shares at $16.00 ($5,000,000)
- Director acquired 1,875,013 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Pardo Geoffrey B · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-09 | Conversion : show line 1 in the form | +1,875,013 | 1,875,013 | I | ||
| 2026-02-09 | Purchase : show line 2 in the form | +312,500 | $16.00 | $5,000,000 | 2,187,513 | I |
| Open-market purchases · 312,500 sh · avg $16.00 · $5,000,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-09 | Conversion : show line 3 in the form Series D Preferred Stock | −1,875,013 | 0 | I |
Loading xslF345X05/form4-02112026_090232.xml…